Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion
Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27 Piramal Pharma expects to sustain mid-teen revenue growth…
Piramal Pharma open to partnerships in OTC; eyes further debt reduction
Piramal Pharma is open to partnerships in the over-the-counter (OTC) space in India as it charts out plans for organic growth and debt reduction. The company has been consistently reducing…
